Primary human bone marrow-derived mesenchymal stem cells (MSCs) treated with TNFa ligand

ABSTRACT: Primary human bone marrow-derived mesenchymal stem cells (MSCs) were treated with recombinant human TNFa (50ng/ml) for different time points (1, 3, 7, 14, 24 hours)

ORGANISM(S): Homo sapiens

SUBMITTER: Khalid Abnaof 

PROVIDER: E-MTAB-5421 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress